Loading the section…
The price of Beta Bionics, Inc. (BBNX) on October 9, 2026 is 17.63 USD, +1.15% on the day. Over 52 weeks the stock traded between 8.80 USD and 32.71 USD; the price now sits 37% of the way up that range. Over the past year the price changed by -20.33%. Market capitalization is 785.62 million USD, rank 35 among 98 stocks of the same industry with a known capitalization.
Closing prices for 9 October 2026
Next earnings report: 27 October 2026, after market close · Earnings calendar
Change over the period shown (line colour): −20.41 %
Beta Bionics, Inc. trades on Nasdaq under the ticker BBNX. The company belongs to the Health care sector. The trading history on this page starts on 30 January 2025.
Over the past 52 weeks BBNX has traded between 8.80 $ and 32.71 $. As of 9 October 2026 the price stood 36.93 % of the way from the 52-week low to the high.
Over one year BBNX shares fell 20.33 %; over six months they rose 98.98 %. Volatility over 90 days is 74.86 %. Dividends are not included: this is price change only, as of 9 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to sales is 7.1, above the sector median of 4.0. Price to book is 2.9, above the sector median of 2.5. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 9 October 2026 | 17.47 | 17.88 | 17.12 | 17.63 | 955,100 |
| 8 October 2026 | 17.96 | 18.04 | 17.07 | 17.43 | 1M |
| 7 October 2026 | 18.91 | 19.11 | 17.93 | 18.08 | 2M |
| 6 October 2026 | 18.91 | 19.24 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
Beta Bionics, Inc. (BBNX) is a public company in the healthcare sector. Its common stock trade on NASDAQ.
Over the trailing twelve months as reported to 2026-03-31, revenue was 110.2m $, net income was -66.4m $. Incorporated in US.
This summary is compiled automatically from SEC filings and exchange data.
Address:11 HUGHES, IRVINE, CA, 92618, US
Beta Bionics, Inc. reported revenue of 110M $ and a net loss of 66M $ over the last four quarters. Net margin is −60.27 %. Revenue changed by +57.87 % year over year. Earnings per share are −1.37 $. Market capitalisation is 786M $.
BBNX has a return on equity of −24.49 %, above the sector median of −41.68 %. Return on assets is −21.82 %, above the sector median of −32.11 %. Operating margin is −70.13 %, below the sector median of −26.84 %.
| 328M |
| DXCMDexCom, Inc. | 84.11 | −0.36 % | 324M |
| MDLNMedline Inc. | 36.26 | +1.45 % | 297M |
| RMDResMed Inc. | 230.05 | +1.46 % | 271M |
| PODDInsulet Corporation | 135.28 | +0.60 % | 244M |
| 18.31 |
| 18.63 |
| 922,800 |
| 5 October 2026 | 18.91 | 19.27 | 18.74 | 18.95 | 624,600 |
| 2 October 2026 | 18.87 | 19.26 | 18.27 | 18.96 | 515,100 |
| 1 October 2026 | 19.35 | 19.44 | 18.39 | 18.87 | 1M |
| 30 September 2026 | 19.22 | 19.52 | 18.45 | 18.98 | 1M |
| 29 September 2026 | 20.61 | 20.73 | 19.28 | 19.41 | 842,500 |
| 28 September 2026 | 21.50 | 21.70 | 19.93 | 20.52 | 2M |
| 25 September 2026 | 21.74 | 21.98 | 21.25 | 21.51 | 926,000 |
| 24 September 2026 | 22.31 | 22.62 | 21.44 | 21.76 | 906,800 |
| 23 September 2026 | 23.00 | 23.48 | 21.88 | 22.19 | 1M |
| 22 September 2026 | 22.18 | 23.56 | 22.10 | 22.81 | 999,600 |
| 21 September 2026 | 22.11 | 22.48 | 21.78 | 22.04 | 783,300 |
| 18 September 2026 | 21.30 | 22.16 | 21.10 | 21.89 | 2M |
| 17 September 2026 | 22.46 | 22.66 | 20.39 | 21.43 | 3M |
| 16 September 2026 | 18.61 | 22.22 | 18.40 | 22.18 | 7M |
| 15 September 2026 | 16.73 | 19.55 | 16.37 | 19.23 | 2M |
| 14 September 2026 | 15.52 | 17.60 | 15.51 | 16.73 | 2M |